S-005151

N/A

Report date: 2024/08/27 11:13:18
NME

Base Information

Drug NameS-005151
Drug Alias NameRedasemtideS-005151
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionStem cells modulators
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeEpidermolysis BullosaStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[18] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesStemrim
China Registration ClassN/A

Develop Information

Active CompaniesStemrimFuji Yakuhin Co LtdShionogi & Co Ltd +[5] 
Inactive CompaniesN/A
Active IndicationsIschemic StrokeEpidermolysis BullosaStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A